| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ceo/ CFO | CEO, CFO | CEO And CFO
1 company
Jorden David Emerson is a Ceo/ CFO at AURX. Recent filings cover 2 purchases and 10 sales. Those positions are worth an estimated $1.7M at current prices.
Jorden David Emerson's largest disclosed position is in AURX as Ceo/ CFO, worth about $1.7M. Net of sales, the recent Form 4 record there shows accumulation of 22,500 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 28, 2025 | AURX Nuo Therapeutics, Inc. | Ceo/ CFO | Sell | 200,000 | $1.50 | $300,000.00 | -9.3% | |
| Nov 9, 2022 | AURX Nuo Therapeutics, Inc. | Ceo/ CFO | Sell | 162,500 | $1.50 | $243,750.00 | -0.9% | |
| Aug 10, 2017 | AURX Nuo Therapeutics, Inc. | CEO, CFO | Buy | 247,500 | $0.22 | $54,994.50 | +79.9% | |
| May 5, 2016 | AURX Nuo Therapeutics, Inc. | CEO And CFO | Buy | 137,500 | $1.00 | $137,500.00 | New |